Semglutide also promotes an increase in insulin levels while reducing the risk of events like stroke or heart attack
One area that has attracted academic discussion, press coverage, and significant biotechnology/pharma R&D investment is concern about undesirable, collateral skeletal muscle mass (SMM) loss, and presumably by extension, loss of strength and function in people taking GLP-1 medications
Li P, Varghese JS, Shah MK, et al
Exenatide and the treatment of patients with Parkinsons disease
When you have more energy, you use more energy, and when you use more energy, your body uses more fuel (calories)
If youre paying cash, you can access the reduced pricing regardless of whether your prescription is for diabetes or weight loss